5 AM Ventures is one of the Companies that have succeeded in Venture capitalism. The Company has focused its efforts in building and establishing companies that can generate significant returns on their business activities. Venture Capital is a risky form of investment, but the 5 AM Ventures have successfully created a fortune from it.
5 AM Ventures was established to create business solutions in medicine and science. 5 AM has partnered with companies that have developed medical solutions to prevent and cure various conditions. Learn more about Scott Rocklage: https://ideamensch.com/scott-rocklage/
The Company has developed an approach for investing in a new Company. The team will assume the short-term functions of a Company and hand it over to the management after the business stabilizes.
Scott Rocklage is one of the 18 member management team.
About Scott Rocklage
Scott Rocklage is one of the Managing Partner of the 5 AM Ventures Company. Scott joined 5 AM in 2003 and was promoted to the Managing Director in 2004. Before joining the 5 AM Ventures, Scott was serving at the llypsa, Sempurs, and Miikana Companies.
Rocklage has 30 years of experience in the health industry. Over the years, Scott has gained skills that have enabled him to manage his Company. Scott has used his leadership skills to achieve the FDA approval of three Drug applications. Read more: Sccot Racklage | Bloomberg and Scott Racklage | Crunchbase
Scott has served in various Companies in the course of his career. Rocklage has served as the Chairman and C.E.O of the Cubist Pharmaceuticals. He has also served as the Chief Executive Officer and the President of Nycomed Salutar.
Scott Rocklage has served as a member of the Board of Directors for different Companies like Relypsa and Novira. Scott is currently serving as a member of the Board of Directors for Epirus, Cidara, Pulmatrix, and Kinestral.
Scott graduated from the University of California with a Bachelor of Science in Chemistry. He later advanced his education and achieved his Master degree and Ph.D. in Chemistry from Massachusetts Institute of Technology. Scott engaged in a research and published peer-reviewed reports and articles. Scott has co-invented 30 United States Patents. Scott is based in Boston, MA.